You are here
- Home
- Drug Products
- All Drug Products
A phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD5423 after Administration of Single and Multiple Ascending Doses in Healthy Male Japanese Subjects
- Drug Name
- AZD5423
- Generic Name
- AZD5423
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D2340C00003
- Study Id
- D2340C00003
- ClinicalTrials.gov ID
- NCT01338350
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
